Related Experiment Video

Updated: Sep 27, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.6K

2021. The year in review. Structural heart interventions

Konstantinos Marmagkiolis1, Cezar A Iliescu2, Cindy L Grines3

  • 1Cardiology, University of Texas, MD Anderson Cancer Center, Houston, TX, United States of America; Cardiology, Univeristy of South Florida, Tampa, FL, United States of America.

International Journal of Cardiology
|April 15, 2022
PubMed

Insights

The COVID-19 pandemic significantly impacted cardiology, shifting conferences online and delaying structural heart interventions and clinical trials. This review offers an overview for cardiologists interested in structural heart interventions.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology

Background:

  • The COVID-19 pandemic profoundly altered medical practices starting in 2020.
  • Virtual platforms largely replaced in-person cardiology conferences.
  • Significant disruptions occurred in elective structural heart interventions and clinical research.

Purpose of the Study:

  • To provide a comprehensive overview of structural heart interventions.
  • To address the impact of the COVID-19 pandemic on the field.
  • To inform general and interventional cardiologists.

Main Methods:

  • Review of the impact of the COVID-19 pandemic on cardiology practice.
  • Analysis of changes in structural heart interventions.
  • Examination of setbacks in clinical research and trials.

Main Results:

  • Decline in elective structural heart interventions observed.
  • Major setbacks reported in academic and industry-sponsored clinical trials.
  • Shift towards virtual conferences became the norm.

Conclusions:

  • The pandemic necessitated adaptation in cardiology practice and research.
  • Structural heart intervention landscape has been reshaped.
  • Continuous review and adaptation are crucial for the field's progression.

Keywords:
2021LAAOMitraClipPFOStructuralTAVR

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.4K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.8K

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
44
Overview of the Heart01:07

Overview of the Heart

The heart, a muscular organ located in the chest, functions as the body's pump, circulating blood through the vascular system. It has four chambers: two atria on top and two ventricles below. The right atrium receives deoxygenated blood from the body and passes it to the right ventricle, which pumps it to the lungs for oxygenation. The left atrium receives oxygenated blood from the lungs and transfers it to the left ventricle, which pumps it to the rest of the body.
The heart's structure...
7.4K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
36
Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
6.1K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
78
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.5K